THE ROLE OF CLINICAL AND GENETIC DETERMINANTS IN THE DEVELOPMENT OF CARDIOMETABOLIC AND RENAL COMPLICATIONS IN PATIENTS WITH GOUT
PODAGRA BILAN OG‘RIGAN BEMORLARDA KARDIOMЕTABOLIK VA RЕNAL ASORATLARNING SHAKLLANISHIDA KLINIK-GENETIK DETERMINANTLARNING ROLI
<p>This study investigated the relationship between metabolic syndrome (MS), cardiorenal syndrome (CRS), and overall coronary risk (OCR) and genetic determinants in patients with gout. A total of 90 patients were enrolled, and their clinical and laboratory parameters were analyzed in relation to polymorphisms in the VEGFA, eNOS, MTHFR, ABCD2, and MTR genes. A high cardiometabolic risk was identified in 54.4% of the patients. The Val allele of the MTHFR gene (OR = 3.4) and the G/G genotype of the VEGFA gene were identified as major risk factors. Furthermore, serum uric acid levels showed a strong association with reduced renal filtration (r = 0.72) and hepatic steatosis.</p>
Сведения
- Опубликовано
- 2026 · Т. 4, № 15, С. 311-315
- Язык
- Английский
- ISSN
- 2992-8958
- Издатель
- Nashr Matbaa Uyi MCHJ